Eisai Co. Ltd.'s Fiscal Year is From April To March - All Figures are in JPY, Billions.
The item "Total-Other-Finance-Cost" stands at -4.22 Billion Japanese Yens for the trailing twelve months (TTM) period ending 09/30/2025, the lowest value since 09/30/2015.
Eisai Co. Ltd.'s second quarter result of -1.44 Billion JPY for the item "Total Other Finance Cost" represents a decrease of -57.42 percent compared to it's first quarter result.
Also, Eisai Co. Ltd.'s second quarter result of -1.44 Billion JPY for the item "Total Other Finance Cost" represents a decrease of -53.90 percent compared to it's second quarter result of last year.
Looking again at the trailing twelve months series (TTM), Eisai Co. Ltd.'s second quarter result of -4.22 Billion JPY for the item "Total Other Finance Cost" represents a decrease of -13.58 percent compared to it's first quarter result.
Regarding the One-Year-Change of the series, the current value constitutes an decrease of -2.57 Billion Japanese Yens compared to the value the year prior.
The 1 year change is -2.57 Billion Japanese Yens.
The 10 year change is -0.211 Billion Japanese Yens.
| Logo | Name | Market Cap (USD) |
|---|---|---|
![]() | Eli Lilly and Company - Total Other Finance Cost | 905,699,262,464.00 |
![]() | Johnson & Johnson - Total Other Finance Cost | 486,508,953,600.00 |
![]() | AbbVie Inc - Total Other Finance Cost | 399,570,305,024.00 |
![]() | Roche Holding AG - Total Other Finance Cost | 317,433,206,677.55 |
![]() | AstraZeneca PLC - Total Other Finance Cost | 280,205,508,085.11 |